J AUTOIMMUN 润色咨询

JOURNAL OF AUTOIMMUNITY

出版年份:1988 年文章数:878 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:5.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2024-04-08 14706479m35(暂无昵称) 来自山东省

    偏重的研究方向:哮喘;巨噬细胞
    经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process

    8

    展开8条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2022-05-05 Mis 吴

    有没有人可以分享一下投稿进程?谢谢

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2024-03-11 1487e742m42(暂无昵称) 来自内蒙古

    偏重的研究方向:免疫
    经验分享:2024.03.08 submitted to journal
    2024.03.08 with editor
    投稿时忘记上传WB 的原始图片PDF了。。。

    10

    展开10条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2024-03-19 ms3236964720522021 来自陕西省

    提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2024-01-01 ms3000000202046104 来自吉林省

    请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2023-12-12 ms7000001739408141 来自北京

    有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2019-04-17 138200c9a8m

    综述要约稿吗?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    上传文章时应该上传word还是pdf?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-12-27 rayms

    什么是推荐reviewer/专家/同行?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2197439, encodeId=fa4c219e4396e, content=偏重的研究方向:哮喘;巨噬细胞<br>经验分享:来积攒人品。3月21日提交,3月22日with editor ,4月6日decision in process,目前还是decision in process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fed15185369, createdName=14706479m35(暂无昵称), createdTime=Mon Apr 08 19:19:48 CST 2024, time=2024-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1217049, encodeId=239f121e049dd, content=有没有人可以分享一下投稿进程?谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Thu May 05 14:06:39 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192591, encodeId=259b219259102, content=偏重的研究方向:免疫<br>经验分享:2024.03.08 submitted to journal<br>2024.03.08 with editor<br>投稿时忘记上传WB 的原始图片PDF了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffcd5307805, createdName=1487e742m42(暂无昵称), createdTime=Mon Mar 11 15:27:07 CST 2024, time=2024-03-11, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2193998, encodeId=f568219399892, content=提交到期刊近20天没有变化,杂志首页却介绍首个决定5天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/n4IYDdvYfkjeLr8oiaPal0dQa93Zgia4eCSXxEJrEoviaPdbED0F1HbgT84Xfl8v7mTjsHNkG5sK8fxVjBrU4N8XQ/132, createdBy=00212440140, createdName=ms3236964720522021, createdTime=Tue Mar 19 08:56:09 CST 2024, time=2024-03-19, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2178587, encodeId=89a521e85875b, content=请问各位大佬,jornal of autoimmunity投稿对摘要和全文没有字数要求吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7be6461276, createdName=ms3000000202046104, createdTime=Mon Jan 01 14:08:20 CST 2024, time=2024-01-01, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2174377, encodeId=290a21e4377e3, content=有哪位大神可以告知一下,为什么投稿第二步,attach files 总过不去,也上传文件了,就是不行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e759104536, createdName=ms7000001739408141, createdTime=Tue Dec 12 07:08:18 CST 2023, time=2023-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=569627, encodeId=b9dd56962ea6, content=综述要约稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce9a2150313, createdName=138200c9a8m, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092553, encodeId=deab109255326, content=上传文章时应该上传word还是pdf?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092554, encodeId=4fb81092554b3, content=什么是推荐reviewer/专家/同行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-08-04 医者仁者

    协和医院发的多

    0

共50条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分